Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Systemic and local interferon-gamma production following Mycobacterium ulcerans infection.

Schipper HS, Rutgers B, Huitema MG, Etuaful SN, Westenbrink BD, Limburg PC, Timens W, van der Werf TS.

Clin Exp Immunol. 2007 Dec;150(3):451-9. Epub 2007 Sep 27.

2.

A stepwise approach to the laboratory diagnosis of Buruli ulcer disease.

Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, Klutse E, Crofts K, Massavon W, Etuaful S, Thompson R, Asamoah-Opare K, Racz P, Vloten F, van Berberich C, Kruppa T, Ampadu E, Fleischer B, Adjei O.

Trop Med Int Health. 2007 Jan;12(1):89-96.

3.

Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response.

Phillips R, Horsfield C, Mangan J, Laing K, Etuaful S, Awuah P, Nyarko K, Osei-Sarpong F, Butcher P, Lucas S, Wansbrough-Jones M.

Infect Immun. 2006 May;74(5):2917-24.

4.

Cytokine response to antigen stimulation of whole blood from patients with Mycobacterium ulcerans disease compared to that from patients with tuberculosis.

Phillips R, Horsfield C, Kuijper S, Sarfo SF, Obeng-Baah J, Etuaful S, Nyamekye B, Awuah P, Nyarko KM, Osei-Sarpong F, Lucas S, Kolk AH, Wansbrough-Jones M.

Clin Vaccine Immunol. 2006 Feb;13(2):253-7.

5.

Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.

Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, Etuaful S, Raghunathan PL, Whitney EA, Ampadu EO, Asamoa K, Klutse EY, te Meerman GJ, Tappero JW, Ashford DA, van der Steege G.

Genes Immun. 2006 Apr;7(3):185-9.

PMID:
16395392
6.

Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients.

Stienstra Y, van Roest MH, van Wezel MJ, Wiersma IC, Hospers IC, Dijkstra PU, Johnson RC, Ampadu EO, Gbovi J, Zinsou C, Etuaful S, Klutse EY, van der Graaf WT, van der Werf TS.

Trop Med Int Health. 2005 Dec;10(12):1251-7.

7.

Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an Assay using punch biopsy specimens for diagnosis of Buruli ulcer.

Phillips R, Horsfield C, Kuijper S, Lartey A, Tetteh I, Etuaful S, Nyamekye B, Awuah P, Nyarko KM, Osei-Sarpong F, Lucas S, Kolk AH, Wansbrough-Jones M.

J Clin Microbiol. 2005 Aug;43(8):3650-6.

8.

Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.

Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu E, Amofah G, Asiedu K, Wansbrough-Jones M.

Antimicrob Agents Chemother. 2005 Aug;49(8):3182-6.

9.

Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana.

Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH Jr, Amofah GK, Ofori-Adjei D, Dobos K, Guarner J, Martin S, Pathak S, Klutse E, Etuaful S, van der Graaf WT, van der Werf TS, King CH, Tappero JW, Ashford DA.

Clin Infect Dis. 2005 May 15;40(10):1445-53. Epub 2005 Apr 12.

PMID:
15844067
10.

Reliability and validity of the Buruli ulcer functional limitation score questionnaire.

Stienstra Y, Dijkstra PU, Van Wezel MJ, Van Roest MH, Beets M, Zijlstra I, Johnson RC, Ampadu EO, Gbovi J, Zinsou C, Etuaful S, Klutse EY, Van der Graaf WT, Van der Werf TS.

Am J Trop Med Hyg. 2005 Apr;72(4):449-52.

PMID:
15827284
11.

Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission.

Hospers IC, Wiersma IC, Dijkstra PU, Stienstra Y, Etuaful S, Ampadu EO, van der Graaf WT, van der Werf TS.

Trans R Soc Trop Med Hyg. 2005 Mar;99(3):196-201.

PMID:
15653121
12.

Buruli ulcer and schistosomiasis: no association found.

Stienstra Y, van der Werf TS, van der Graaf WT, Secor WE, Kihlstrom SL, Dobos KM, Asamoa K, Quarshi E, Etuaful SN, Klutse EY, King CH.

Am J Trop Med Hyg. 2004 Sep;71(3):318-21.

PMID:
15381813
13.

Development of a questionnaire assessing Buruli ulcer-induced functional limitation.

Stienstra Y, Dijkstra PU, Guédénon A, Johnson RC, Ampadu EO, Mensah T, Klutse EY, Etuaful S, Deepak S, Van Der Graaf WT, Van Der Werf TS.

Am J Trop Med Hyg. 2004 Mar;70(3):318-22.

PMID:
15031524
14.

An outreach education and treatment project in Ghana for the early stage of Mycobacterium ulcerans disease.

Evans MR, Phillips R, Etuaful SN, Amofah G, Adomako J, Adjei O, Dennis-Antwi J, Lucas SB, Wansbrough-Jones MH.

Trans R Soc Trop Med Hyg. 2003 Mar-Apr;97(2):159-60.

PMID:
14584368
15.

Histopathologic features of Mycobacterium ulcerans infection.

Guarner J, Bartlett J, Whitney EA, Raghunathan PL, Stienstra Y, Asamoa K, Etuaful S, Klutse E, Quarshie E, van der Werf TS, van der Graaf WT, King CH, Ashford DA.

Emerg Infect Dis. 2003 Jun;9(6):651-656.

16.

Phenolic glycolipid-1 (PGL-1) in Buruli ulcer lesions. First demonstration by immuno-histochemistry.

Mwanatambwe M, Yajima M, Etuaful S, Fukunishi Y, Suzuki K, Asiedu K, Yamada N, Asanao G.

Int J Lepr Other Mycobact Dis. 2002 Sep;70(3):201-5.

PMID:
12483968
17.

Malignant melanoma of the buttock presenting as a Buruli ulcer.

Mwanatambwe M, Yajima M, Etuaful S, Suzuki K, Nishigai K, Asiedu K, Yamada N, Asano G.

J Dermatol. 2002 Jun;29(6):357-61.

PMID:
12126073
18.

Squamous cell carcinoma secondary to Buruli ulcer.

Evans MR, Etuaful SN, Amofah G, Adjei O, Lucas S, Wansbrough-Jones MH.

Trans R Soc Trop Med Hyg. 1999 Jan-Feb;93(1):63-4. No abstract available.

PMID:
10492793
19.

Socioeconomic implications of Buruli ulcer in Ghana: a three-year review.

Asiedu K, Etuaful S.

Am J Trop Med Hyg. 1998 Dec;59(6):1015-22.

PMID:
9886216

Supplemental Content

Loading ...
Support Center